Form 4: BIO-TECHNE Director Reports Stock Transaction
Insider Transaction (Form 4)
John L Higgins, a Director of BIO-TECHNE Corp, reported multiple transactions in common stock on September 28, 2026.
Summary
- Option exercise/conversion: acquired 15,940 Common Stock on September 28, 2026; holds 82,816 after (Direct).
- Tax/exercise-price withholding: disposed of 5,562 Common Stock at $72.51 ($403,301) on September 28, 2026; holds 77,254 after (Direct).
- Option exercise/conversion: disposed of 15,940 Stock Options (Right to Buy) on September 28, 2026 (Direct).
Sentiment
Score: 5
Explanation: StockSavvy.ai views this as routine: the reported changes are grants, option exercises, tax withholding or similar administrative transactions, which carry limited directional signal.
Insider Transactions
John L Higgins — Director
| Date | Transaction | Security | Shares | Price | Value | Held After |
|---|---|---|---|---|---|---|
| 2026-09-28 | Option exercise/conversion | Common Stock | 15,940 | — | — | 82,816 |
| 2026-09-28 | Tax/exercise-price withholding | Common Stock | 5,562 | $73 | $403.3K | 77,254 |
| 2026-09-28 | Option exercise/conversion | Stock Options (Right to Buy) | 15,940 | — | — | 0 |
Key Dates
| Date | Description |
|---|---|
| 2026-09-28 | Option exercise/conversion (15,940 shares) |
| 2026-09-28 | Tax/exercise-price withholding (5,562 shares) |
| 2026-09-28 | Option exercise/conversion (15,940 shares) |
Keywords
insider transaction, Form 4, TECH, BIO-TECHNE Corp, neutral, John L Higgins
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.